Pamela Drullinsky
Impact in
Papers in
- Oncology 38
- Cancer Treatment and Pharmacology 26
- HER2/EGFR in Cancer Research 18
- Viral-associated cancers and disorders 6
-
- Advanced Breast Cancer Therapies 22
- Co-authors
- Monika Engelhardt (4 shared papers)Malcolm A.S. Moore (3 shared papers)J G Guillem (2 shared papers)Karen L. MacKenzie (1 shared paper)Richard T. Silver (1 shared paper)Hope S. Rugo (12 shared papers)Dejan Juric (12 shared papers)Florence Lerebours (12 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Cancer Research (10 papers)Breast Cancer Research and Treatment (5 papers)Blood (5 papers)Clinical Breast Cancer (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Pamela Drullinsky
56 papers receiving 1.3k citations
Pamela Drullinsky's Hit Papers
Peers
Comparison fields: 5 of 64
- Genetics 294
- Oncology 611
- Cancer Research 220
- Pulmonary and Respiratory Medicine 478
- Physiology 361
Countries citing papers authored by Pamela Drullinsky
This map shows the geographic impact of Pamela Drullinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Drullinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Drullinsky more than expected).
Fields of papers citing papers by Pamela Drullinsky
This network shows the impact of papers produced by Pamela Drullinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Drullinsky. The network helps show where Pamela Drullinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Pamela Drullinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study Hit paper breakdown → | 2021 | 223 |
| 2 | Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. | 1997 | 157 |
| 3 | 2020 | 116 | |
| 4 | Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. | 2000 | 116 |
| 5 | 2018 | 105 | |
| 6 | 1998 | 78 | |
| 7 | Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. | 1997 | 72 |
| 8 | 2018 | 49 | |
| 9 | 2008 | 44 | |
| 10 | 2020 | 35 | |
| 11 | 2020 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2019 | 26 | |
| 14 | 2014 | 25 | |
| 15 | 2008 | 23 | |
| 16 | 2016 | 20 | |
| 17 | 2011 | 19 | |
| 18 | 1998 | 16 | |
| 19 | 2011 | 14 | |
| 20 | 2023 | 13 |
About Pamela Drullinsky
Pamela Drullinsky is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Advanced Breast Cancer Therapies (22 papers), HER2/EGFR in Cancer Research (18 papers), Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), Breast Cancer Treatment Studies (7 papers), Viral-associated cancers and disorders (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Genetics (294 citations), Oncology (611 citations), Cancer Research (220 citations), Pulmonary and Respiratory Medicine (478 citations) and Physiology (361 citations). Pamela Drullinsky has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Monika Engelhardt, Malcolm A.S. Moore, J G Guillem, Karen L. MacKenzie, Richard T. Silver, Hope S. Rugo, Dejan Juric, Florence Lerebours, Nicholas C. Turner and Stephen Chia. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Blood and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.